Read news on miR-125b-5p with our app.
Read more in the app
Metabolic dysfunction-associated steatotic liver disease diminishes the efficacy of miR-125b-5p-engineered MSC therapy for hepatocellular carcinoma via HK2 upregulation - EurekAlert!
